{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:43:07Z","timestamp":1791409387137,"version":"4.3.3"},"reference-count":56,"publisher":"American Association for Cancer Research (AACR)","issue":"24","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The chemokine receptor CXCR4 is expressed in many cancers where it may regulate tumor cell growth and migration. The role of CXCR4 in cancer will depend on it being in an activated, signaling state. To better define the significance of CXCR4 expression in cancer, we developed an antibody that can distinguish CXCR4 phosphorylated on serine 339, a residue previously identified as a site for ligand-induced phosphorylation. With this antibody, we investigated the mechanisms of CXCR4 phosphorylation and evaluated the phosphorylation status of CXCR4 in human astrocytomas. In vitro, phosphorylation of serine 339 occurred in response to CXCL12 or epidermal growth factor (EGF) treatment and was increased by protein kinase C activation. In all grades of astrocytomas, CXCR4 was expressed in tumor cells and some endothelial cells, whereas CXCL12 was present in endothelial cells and infiltrating microglia. We found that CXCR4 phosphorylated on serine 339 was present in tumor cells and vascular endothelial cells in all grades of astrocytoma. These data indicate that CXCR4 is expressed and activated in astrocytomas and that phosphorylation of CXCR4 can occur through ligand activation or transactivation via the EGF receptor. These studies extend the potential roles of CXCR4 in cancer to include functions associated with benign (grade 1) tumors. The ability to distinguish phosphorylated CXCR4 will be invaluable for the continued analysis of the role of CXCR4 in cancer and the development of CXCR4 antagonist therapy for patients suffering with primary tumors of the brain and other sites. (Cancer Res 2005; 65(24): 11392-9)<\/jats:p>","DOI":"10.1158\/0008-5472.can-05-0847","type":"journal-article","created":{"date-parts":[[2005,12,15]],"date-time":"2005-12-15T12:57:39Z","timestamp":1134651459000},"page":"11392-11399","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["Widespread CXCR4 Activation in Astrocytomas Revealed by Phospho-CXCR4-Specific Antibodies"],"prefix":"10.1158","volume":"65","author":[{"given":"B. Mark","family":"Woerner","sequence":"first","affiliation":[{"name":"1Department of Pediatrics, Divisions of Pediatric Hematology\/Oncology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Warrington","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Divisions of Pediatric Hematology\/Oncology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Kung","sequence":"additional","affiliation":[{"name":"5Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie","family":"Perry","sequence":"additional","affiliation":[{"name":"2Neuropathology;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua B.","family":"Rubin","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Divisions of Pediatric Hematology\/Oncology and"},{"name":"3Departments of Anatomy and Neurobiology and"},{"name":"4Neurology, Washington University School of Medicine, St. Louis, Missouri; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2005,12,15]]},"reference":[{"key":"2022061621071496100_B1","doi-asserted-by":"crossref","unstructured":"Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol\u20082004;14:171\u20139.","DOI":"10.1016\/j.semcancer.2003.10.003"},{"key":"2022061621071496100_B2","doi-asserted-by":"crossref","unstructured":"Zlotnik A. Chemokines in neoplastic progression. Semin Cancer Biol\u20082004;14:181\u20135.","DOI":"10.1016\/j.semcancer.2003.10.004"},{"key":"2022061621071496100_B3","doi-asserted-by":"crossref","unstructured":"Rubin JB, Kung AL, Klein RS, et al. A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci U S A\u20082003;100:13513\u20138.","DOI":"10.1073\/pnas.2235846100"},{"key":"2022061621071496100_B4","doi-asserted-by":"crossref","unstructured":"Smith MC, Luker KE, Garbow JR, et al. CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res\u20082004;64:8604\u201312.","DOI":"10.1158\/0008-5472.CAN-04-1844"},{"key":"2022061621071496100_B5","doi-asserted-by":"crossref","unstructured":"Lataillade JJ, Clay D, Dupuy C, et al. Chemokine SDF-1 enhances circulating CD34(+) cell proliferation in synergy with cytokines: possible role in progenitor survival. Blood\u20082000;95:756\u201368.","DOI":"10.1182\/blood.V95.3.756"},{"key":"2022061621071496100_B6","doi-asserted-by":"crossref","unstructured":"Lataillade JJ, Clay D, Bourin P, et al. Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)\/G(1) transition in CD34(+) cells: evidence for an autocrine\/paracrine mechanism. Blood\u20082002;99:1117\u201329.","DOI":"10.1182\/blood.V99.4.1117"},{"key":"2022061621071496100_B7","doi-asserted-by":"crossref","unstructured":"Rosu-Myles M, Bhatia M. SDF-1 enhances the expansion and maintenance of highly purified human hematopoietic progenitors. Hematol J\u20082003;4:137\u201345.","DOI":"10.1038\/sj.thj.6200233"},{"key":"2022061621071496100_B8","doi-asserted-by":"crossref","unstructured":"Klein RS, Rubin JB, Gibson HD, et al. SDF-1\u03b1 induces chemotaxis and enhances Sonic hedgehog-induced proliferation of cerebellar granule cells. Development\u20082001;128:1971\u201381.","DOI":"10.1242\/dev.128.11.1971"},{"key":"2022061621071496100_B9","doi-asserted-by":"crossref","unstructured":"Lu M, Grove EA, Miller RJ. Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor. Proc Natl Acad Sci U S A\u20082002;99:7090\u20135.","DOI":"10.1073\/pnas.092013799"},{"key":"2022061621071496100_B10","doi-asserted-by":"crossref","unstructured":"Bagri A, Gurney T, He X, et al. The chemokine SDF1 regulates migration of dentate granule cells. Development\u20082002;129:4249\u201360.","DOI":"10.1242\/dev.129.18.4249"},{"key":"2022061621071496100_B11","doi-asserted-by":"crossref","unstructured":"Chalasani SH, Baribaud F, Coughlan CM, et al. The chemokine stromal cell-derived factor-1 promotes the survival of embryonic retinal ganglion cells. J Neurosci\u20082003;23:4601\u201312.","DOI":"10.1523\/JNEUROSCI.23-11-04601.2003"},{"key":"2022061621071496100_B12","doi-asserted-by":"crossref","unstructured":"Schuller U, Koch A, Hartmann W, et al. Subtype-specific expression and genetic alterations of the chemokinereceptor gene CXCR4 in medulloblastomas. Int J Cancer\u20082005;117:82\u20139.","DOI":"10.1002\/ijc.21116"},{"key":"2022061621071496100_B13","doi-asserted-by":"crossref","unstructured":"De Clercq E. The bicyclam AMD3100 story. Nat Rev Drug Discov\u20082003;2:581\u20137.","DOI":"10.1038\/nrd1134"},{"key":"2022061621071496100_B14","doi-asserted-by":"crossref","unstructured":"Gerlach LO, Skerlj RT, Bridger GJ, Schwartz TW. Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor. J Biol Chem\u20082001;276:14153\u201360.","DOI":"10.1074\/jbc.M010429200"},{"key":"2022061621071496100_B15","doi-asserted-by":"crossref","unstructured":"Hatse S, Princen K, Bridger G, De Clercq E, Schols D. Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. FEBS Lett\u20082002;527:255\u201362.","DOI":"10.1016\/S0014-5793(02)03143-5"},{"key":"2022061621071496100_B16","doi-asserted-by":"crossref","unstructured":"Hendrix CW, Flexner C, MacFarland RT, et al. Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob Agents Chemother\u20082000;44:1667\u201373.","DOI":"10.1128\/AAC.44.6.1667-1673.2000"},{"key":"2022061621071496100_B17","doi-asserted-by":"crossref","unstructured":"Haribabu B, Richardson RM, Fisher I, et al. Regulation of human chemokine receptors CXCR4. Role of phosphorylation in desensitization and internalization. J Biol Chem\u20081997;272:28726\u201331.","DOI":"10.1074\/jbc.272.45.28726"},{"key":"2022061621071496100_B18","doi-asserted-by":"crossref","unstructured":"Orsini MJ, Parent JL, Mundell SJ, Marchese A, Benovic JL. Trafficking of the HIV coreceptor CXCR4: role of arrestins and identification of residues in the C-terminal tail that mediate receptor internalization. J Biol Chem\u20082000;275:25876.","DOI":"10.1016\/S0021-9258(19)62160-5"},{"key":"2022061621071496100_B19","doi-asserted-by":"crossref","unstructured":"Signoret N, Oldridge J, Pelchen-Matthews A, et al. Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4. J Cell Biol\u20081997;139:651\u201364.","DOI":"10.1083\/jcb.139.3.651"},{"key":"2022061621071496100_B20","doi-asserted-by":"crossref","unstructured":"Cheng ZJ, Zhao J, Sun Y, et al. \u03b2-arrestin differentially regulates the chemokine receptor CXCR4-mediated signaling and receptor internalization, and this implicates multiple interaction sites between \u03b2-arrestin and CXCR4. J Biol Chem\u20082000;275:2479\u201385.","DOI":"10.1074\/jbc.275.4.2479"},{"key":"2022061621071496100_B21","doi-asserted-by":"crossref","unstructured":"Sun Y, Cheng Z, Ma L, Pei G. \u03b2-arrestin 2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation. J Biol Chem\u20082002;277:49212\u20139.","DOI":"10.1074\/jbc.M207294200"},{"key":"2022061621071496100_B22","doi-asserted-by":"crossref","unstructured":"Wang J, Guan E, Roderiquez G, Calvert V, Alvarez R, Norcross MA. Role of tyrosine phosphorylation in ligand-independent sequestration of CXCR4 in human primary monocytes-macrophages. J Biol Chem\u20082001;276:49236\u201343.","DOI":"10.1074\/jbc.M108523200"},{"key":"2022061621071496100_B23","doi-asserted-by":"crossref","unstructured":"Su SB, Gong W, Grimm M, et al. Inhibition of tyrosine kinase activation blocks the down-regulation of CXC chemokine receptor 4 by HIV-1 gp120 in CD4+ T cells. J Immunol\u20081999;162:7128\u201332.","DOI":"10.4049\/jimmunol.162.12.7128"},{"key":"2022061621071496100_B24","doi-asserted-by":"crossref","unstructured":"Segal RA, Bhattacharyya A, Rua LA, et al. Differential utilization of Trk autophosphorylation sites. J Biol Chem\u20081996;271:20175\u201381.","DOI":"10.1074\/jbc.271.33.20175"},{"key":"2022061621071496100_B25","unstructured":"Cavenee WK, Furnari FB, Nagane M, et al. Astrocytic tumours. In: Kleihues P, Cavenee WK, editors. WHO classification of tumours. Tumours of the central nervous system. Lyon (France): IARC Press; 2000. p. 9\u201354."},{"key":"2022061621071496100_B26","doi-asserted-by":"crossref","unstructured":"Zhou Y, Larsen PH, Hao C, Yong VW. CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem\u20082002;277:49481\u20137.","DOI":"10.1074\/jbc.M206222200"},{"key":"2022061621071496100_B27","doi-asserted-by":"crossref","unstructured":"Salmaggi A, Gelati M, Pollo B, et al. CXCL12 in malignant glial tumors: a possible role in angiogenesis and cross-talk between endothelial and tumoral cells. J Neurooncol\u20082004;67:305\u201317.","DOI":"10.1023\/B:NEON.0000024241.05346.24"},{"key":"2022061621071496100_B28","doi-asserted-by":"crossref","unstructured":"Kryczek I, Lange A, Mottram P, et al. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res\u20082005;65:465\u201372.","DOI":"10.1158\/0008-5472.465.65.2"},{"key":"2022061621071496100_B29","doi-asserted-by":"crossref","unstructured":"Reis RM, Hara A, Kleihues P, Ohgaki H. Genetic evidence of the neoplastic nature of gemistocytes in astrocytomas. Acta Neuropathol (Berl)\u20082001;102:422\u20135.","DOI":"10.1007\/s004010100452"},{"key":"2022061621071496100_B30","unstructured":"Watanabe K, Tachibana O, Yonekawa Y, Kleihues P, Ohgaki H. Role of gemistocytes in astrocytoma progression. Lab Invest\u20081997;76:277\u201384."},{"key":"2022061621071496100_B31","doi-asserted-by":"crossref","unstructured":"Burger PC, Vogel FS, Green SB, Strike TA. Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer\u20081985;56:1106\u201311.","DOI":"10.1002\/1097-0142(19850901)56:5<1106::AID-CNCR2820560525>3.0.CO;2-2"},{"key":"2022061621071496100_B32","doi-asserted-by":"crossref","unstructured":"Kleihues P, Ohgaki H. Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro-oncol\u20081999;1:44\u201351.","DOI":"10.1093\/neuonc\/1.1.44"},{"key":"2022061621071496100_B33","unstructured":"Burger PC, Scheithauer BW, Paulus W, Szymas J, Giannini C, Kleihues P. Pilocytic astrocytoma. In: Kleihues P, Cavenee WK, editors. WHO classification of tumours. Pathology and genetics of tumours of the nervous system. Lyon (France): IARC Press; 2000. p. 45\u201351."},{"key":"2022061621071496100_B34","doi-asserted-by":"crossref","unstructured":"Venkatesan S, Rose JJ, Lodge R, Murphy PM, Foley JF. Distinct mechanisms of agonist-induced endocytosis for human chemokine receptors CCR5 and CXCR4. Mol Biol Cell\u20082003;14:3305\u201324.","DOI":"10.1091\/mbc.e02-11-0714"},{"key":"2022061621071496100_B35","doi-asserted-by":"crossref","unstructured":"Roland J, Murphy BJ, Ahr B, et al. Role of the intracellular domains of CXCR4 in SDF-1-mediated signaling. Blood\u20082003;101:399\u2013406.","DOI":"10.1182\/blood-2002-03-0978"},{"key":"2022061621071496100_B36","doi-asserted-by":"crossref","unstructured":"Guleng B, Tateishi K, Ohta M, et al. Blockade of the stromal cell-derived factor-1\/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner. Cancer Res\u20082005;65:5864\u201371.","DOI":"10.1158\/0008-5472.CAN-04-3833"},{"key":"2022061621071496100_B37","unstructured":"Rempel SA, Dudas S, Ge S, Gutierrez JA. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin Cancer Res\u20082000;6:102\u201311."},{"key":"2022061621071496100_B38","doi-asserted-by":"crossref","unstructured":"Staller P, Sulitkova J, Lisztwan J, Moch H, Oakeley EJ, Krek W. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature\u20082003;425:307\u201311.","DOI":"10.1038\/nature01874"},{"key":"2022061621071496100_B39","doi-asserted-by":"crossref","unstructured":"Salcedo R, Wasserman K, Young HA, et al. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: in vivo neovascularization induced by stromal-derived factor-1\u03b1. Am J Pathol\u20081999;154:1125\u201335.","DOI":"10.1016\/S0002-9440(10)65365-5"},{"key":"2022061621071496100_B40","unstructured":"Bachelder RE, Wendt MA, Mercurio AM. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res\u20082002;62:7203\u20136."},{"key":"2022061621071496100_B41","unstructured":"Cavenee WK, Furnari FB, Nagane M, et al. Astrocytic tumours. In: Kleihues P, Cavenee WK, editors. WHO classification of tumours. Tumours of the central nervous system. Lyon (France): IARC Press; 1999. p. 9\u201354."},{"key":"2022061621071496100_B42","unstructured":"Hermanson M, Funa K, Hartman M, et al. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res\u20081992;52:3213\u20139."},{"key":"2022061621071496100_B43","doi-asserted-by":"crossref","unstructured":"Varela M, Ranuncolo SM, Morand A, et al. EGF-R and PDGF-R, but not bcl-2, overexpression predict overall survival in patients with low-grade astrocytomas. J Surg Oncol\u20082004;86:34\u201340.","DOI":"10.1002\/jso.20036"},{"key":"2022061621071496100_B44","doi-asserted-by":"crossref","unstructured":"Torp SH, Helseth E, Dalen A, Unsgaard G. Epidermal growth factor receptor expression in human gliomas. Cancer Immunol Immunother\u20081991;33:61\u20134.","DOI":"10.1007\/BF01742530"},{"key":"2022061621071496100_B45","doi-asserted-by":"crossref","unstructured":"Guha A, Dashner K, Black PM, Wagner JA, Stiles CD. Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop. Int J Cancer\u20081995;60:168\u201373.","DOI":"10.1002\/ijc.2910600206"},{"key":"2022061621071496100_B46","doi-asserted-by":"crossref","unstructured":"Fuller GN, Bigner SH. Amplified cellular oncogenes in neoplasms of the human central nervous system. Mutat Res\u20081992;276:299\u2013306.","DOI":"10.1016\/0165-1110(92)90016-3"},{"key":"2022061621071496100_B47","doi-asserted-by":"crossref","unstructured":"Libermann TA, Nusbaum HR, Razon N, et al. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature\u20081985;313:144\u20137.","DOI":"10.1038\/313144a0"},{"key":"2022061621071496100_B48","doi-asserted-by":"crossref","unstructured":"Maxwell M, Naber SP, Wolfe HJ, et al. Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance. J Clin Invest\u20081990;86:131\u201340.","DOI":"10.1172\/JCI114675"},{"key":"2022061621071496100_B49","doi-asserted-by":"crossref","unstructured":"Mauro A, Bulfone A, Turco E, Schiffer D. Coexpression of platelet-derived growth factor (PDGF) B chain and PDGF B-type receptor in human gliomas. Childs Nerv Syst\u20081991;7:432\u20136.","DOI":"10.1007\/BF00263184"},{"key":"2022061621071496100_B50","doi-asserted-by":"crossref","unstructured":"Guha A, Glowacka D, Carroll R, Dashner K, Black PM, Stiles CD. Expression of platelet derived growth factor and platelet derived growth factor receptor mRNA in a glioblastoma from a patient with Li-Fraumeni syndrome. J Neurol Neurosurg Psychiatry\u20081995;58:711\u20134.","DOI":"10.1136\/jnnp.58.6.711"},{"key":"2022061621071496100_B51","doi-asserted-by":"crossref","unstructured":"Hirano H, Lopes MB, Laws ER, Jr., et al. Insulin-like growth factor-1 content and pattern of expression correlates with histopathologic grade in diffusely infiltrating astrocytomas. Neuro-oncol\u20081999;1:109\u201319.","DOI":"10.1215\/15228517-1-2-109"},{"key":"2022061621071496100_B52","doi-asserted-by":"crossref","unstructured":"Vazquez-Prado J, Casas-Gonzalez P, Garcia-Sainz JA. G protein-coupled receptor cross-talk: pivotal roles of protein phosphorylation and protein-protein interactions. Cell Signal\u20082003;15:549\u201357.","DOI":"10.1016\/S0898-6568(02)00151-1"},{"key":"2022061621071496100_B53","doi-asserted-by":"crossref","unstructured":"Miller WE, Lefkowitz RJ. Expanding roles for \u03b2-arrestins as scaffolds and adapters in GPCR signaling and trafficking. Curr Opin Cell Biol\u20082001;13:139\u201345.","DOI":"10.1016\/S0955-0674(00)00190-3"},{"key":"2022061621071496100_B54","doi-asserted-by":"crossref","unstructured":"Daaka Y, Luttrell LM, Ahn S, et al. Essential role for G protein-coupled receptor endocytosis in the activation of mitogen-activated protein kinase. J Biol Chem\u20081998;273:685\u20138.","DOI":"10.1074\/jbc.273.2.685"},{"key":"2022061621071496100_B55","doi-asserted-by":"crossref","unstructured":"Packer RJ, Ater J, Allen J, et al. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg\u20081997;86:747\u201354.","DOI":"10.3171\/jns.1997.86.5.0747"},{"key":"2022061621071496100_B56","doi-asserted-by":"crossref","unstructured":"Prados MD, Edwards MS, Rabbitt J, Lamborn K, Davis RL, Levin VA. Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. J Neurooncol\u20081997;32:235\u201341.","DOI":"10.1023\/A:1005736104205"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/65\/24\/11392\/2541756\/11392-11399.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/65\/24\/11392\/2541756\/11392-11399.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T18:30:59Z","timestamp":1683311459000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/65\/24\/11392\/519344\/Widespread-CXCR4-Activation-in-Astrocytomas"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,15]]},"references-count":56,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2005,12,15]]},"published-print":{"date-parts":[[2005,12,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-05-0847","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6494090.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6494090","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22364234","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22364234.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12,15]]}}}